HR 1142 · in committee · significant
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
- healthcare
What this bill does
- The bill requires Medicare to create guidelines aimed at getting patients to take prescribed medications 90% of the time.
- Medicare beneficiaries and drug manufacturers are affected by the new adherence standards and promotion of generic drugs.
- CMS must develop the guidelines using artificial intelligence and machine learning technology to identify and support non-adherent patients.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How might using AI to identify non-adherent patients affect privacy concerns for Medicare beneficiaries whose medication data would be analyzed?
- 02
What trade-offs exist between promoting generic drugs through these guidelines and ensuring patients can access the specific medications their doctors prescribed?
- 03
Which stakeholders—patients, insurers, or drug manufacturers—would bear the costs of implementing and maintaining the AI systems needed to track and improve medication adherence?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-AZ-1
David Schweikert
Citizen cosponsors
0
In Congress
0/ 435
House Reps cosponsoring
Introduced 2025-02-07
Legislative timeline
2025-02-07 · house · IntroReferral
Referred to the House Committee on Energy and Commerce.
2025-02-07 · IntroReferral
Introduced in House
2025-02-07 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.